Results 1 to 10 of about 6,148,992 (233)

Brain Tumors [PDF]

Seminars in Nuclear Medicine, 2012
This review addresses the specific contributions of nuclear medicine techniques, and especially positron emission tomography (PET), for diagnosis and management of brain tumors. (18)F-Fluorodeoxyglucose PET has particular strengths in predicting prognosis and differentiating cerebral lymphoma from nonmalignant lesions.
Herholz, Karl, Langen, Karl Josef, Schiepers, Christiaan, Mountz, James M.   +3 more
openaire   +5 more sources

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.

Neuro-Oncology, 2021
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the CDC and NCI, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US ...
Q. Ostrom, G. Cioffi, K. Waite, C. Kruchko, J. Barnholtz-Sloan   +4 more
semanticscholar   +1 more source

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.

Neuro-Oncology, 2022
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and the National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and ...
Q. Ostrom, M. Price, C. Neff, G. Cioffi, K. Waite, C. Kruchko, J. Barnholtz-Sloan   +6 more
semanticscholar   +1 more source

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.

Neuro-Oncology, 2023
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and the National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and ...
Q. Ostrom, M. Price, C. Neff, G. Cioffi, K. Waite, C. Kruchko, J. Barnholtz-Sloan   +6 more
semanticscholar   +1 more source

Brain tumors [PDF]

CA: A Cancer Journal for Clinicians, 1993
Brain tumors are a relatively common cancer in all age groups, and the incidence of both primary and metastatic brain tumors is increasing. Fortunately, dramatic advances in methods of diagnosis, surgical technique, and adjuvant therapy have all contributed to an improved outlook for patients with brain tumors.
E R, Laws, K, Thapar
openaire   +4 more sources

Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma

Nature Communications, 2023
Senescence can have beneficial and detrimental impact on cancer progression depending on the cellular context. Here the authors show that NRF2 regulates the senescence phenotype in malignant cells which consequently contribute to glioblastoma progression.
Rana Salam, Alexa Saliou, Franck Bielle, Mathilde Bertrand, Christophe Antoniewski, Catherine Carpentier, Agusti Alentorn, Laurent Capelle, Marc Sanson, Emmanuelle Huillard, Léa Bellenger, Justine Guégan, Isabelle Le Roux   +12 more
doaj   +1 more source

The local microenvironment drives activation of neutrophils in human brain tumors.

Cell, 2023
Neutrophils are abundant immune cells in the circulation and frequently infiltrate tumors in substantial numbers. However, their precise functions in different cancer types remain incompletely understood, including in the brain microenvironment.
Roeltje R. Maas, Klara Soukup, Nadine Fournier, Matteo Massara, Sabine Galland, Mara Kornete, Vladimir Wischnewski, Joao Lourenço, Davide Croci, Ángel F. Álvarez-Prado, D. Marie, Johanna Lilja, R. Marcone, Gabriel F. Calvo, Rui Santalla Méndez, Pauline Aubel, Leire Bejarano, P. Wirapati, I. Ballesteros, Andrés Hidalgo, A. Hottinger, J. Brouland, Roy T. Daniel, M. Hegi, Johanna A. Joyce   +24 more
semanticscholar   +1 more source

VRK3 depletion induces cell cycle arrest and metabolic reprogramming of pontine diffuse midline glioma - H3K27 altered cells

Frontiers in Oncology, 2023
We previously identified VRK3 as a specific vulnerability in DMG-H3K27M cells in a synthetic lethality screen targeting the whole kinome. The aim of the present study was to elucidate the mechanisms by which VRK3 depletion impact DMG-H3K27M cell fitness.
Virginie Menez, Thomas Kergrohen, Tal Shasha, Claudia Silva-Evangelista, Ludivine Le Dret, Lucie Auffret, Chloé Subecz, Manon Lancien, Yassine Ajlil, Irma Segoviano Vilchis, Kévin Beccaria, Kévin Beccaria, Thomas Blauwblomme, Estelle Oberlin, Jacques Grill, Jacques Grill, David Castel, Marie-Anne Debily, Marie-Anne Debily   +18 more
doaj   +1 more source

Review and consensus recommendations on clinical APT‐weighted imaging approaches at 3T: Application to brain tumors

Magnetic Resonance in Medicine, 2022
Amide proton transfer‐weighted (APTw) MR imaging shows promise as a biomarker of brain tumor status. Currently used APTw MRI pulse sequences and protocols vary substantially among different institutes, and there are no agreed‐on standards in the imaging ...
Jinyuan Zhou, M. Zaiss, Linda Knutsson, P. Sun, S. Ahn, Silvio Aime, P. Bachert, J. Blakeley, K. Cai, M. Chappell, Min Chen, D. Gochberg, S. Goerke, H. Heo, Shanshan Jiang, T. Jin, Seong-Gi Kim, J. Laterra, D. Paech, M. Pagel, Ji Eun Park, R. Reddy, A. Sakata, S. Sartoretti-Schefer, A. Sherry, Seth A. Smith, G. Stanisz, P. Sundgren, O. Togao, M. Vandsburger, Z. Wen, Yin Wu, Yi Zhang, Wenzhen Zhu, Z. Zu, P. van Zijl   +35 more
semanticscholar   +1 more source

An Effective Approach to Detect and Identify Brain Tumors Using Transfer Learning

Applied Sciences, 2022
Brain tumors are considered one of the most serious, prominent and life-threatening diseases globally. Brain tumors cause thousands of deaths every year around the globe because of the rapid growth of tumor cells. Therefore, timely analysis and automatic
Naeem Ullah, Javed Ali Khan, M. S. Khan, Wahab Khan, Izaz Hassan, M. Obayya, N. Negm, Ahmed S. Salama   +7 more
semanticscholar   +1 more source